Cargando…

Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology

CONTEXT: The primary outcome is to remove the worry of getting immature oocytes with early administration of human chorionic gonadotropin (hCG). AIM: The aim was to find out the association between the day of hCG administration and follicular response in relation to the number and maturity of oocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratap, Deepika, Kumar, Pratap, Adiga, Satish Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150136/ https://www.ncbi.nlm.nih.gov/pubmed/25191023 http://dx.doi.org/10.4103/0974-1208.138868

Ejemplares similares

Advanced Reproductive Technologies and Postponement of Parenthood
por: Sadeghi, Mohammad Reza
Publicado: (2013)

Pre-Ovulatory Hormones on Day of Human Chorionic Gonadotropin Trigger and Assisted Reproductive Technique Outcomes in Different Ovarian Response Groups
por: Mitra, Subarna, et al.
Publicado: (2021)

A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
por: Ezcurra, Diego, et al.
Publicado: (2014)

Effects of human chorionic gonadotropin intrauterine injection on oocyte retrieval day on assisted reproductive techniques outcomes: An RCT
por: Hosseinisadat, Robabe, et al.
Publicado: (2021)

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016)

Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology
por: Patki, Ameet, et al.
Publicado: (2018)

Effect of punicalagin and human chorionic gonadotropin on body weight and reproductive traits in maiden rabbit does.
por: Salem, Anas A., et al.
Publicado: (2020)

Clinical outcomes of assisted reproductive technology treatment by using a self‐injection of recombinant human chorionic gonadotropin as the final maturation trigger
por: Nakagawa, Koji, et al.
Publicado: (2018)

Oocyte retrieval at 140-mmHg negative aspiration pressure: A promising alternative to flushing and aspiration in assisted reproduction in women with low ovarian reserve
por: Kumaran, Aswathy, et al.
Publicado: (2015)

Experimental Production of Gynecomastia with Chorionic Gonadotropin
por: Klatskin, Gerald, et al.
Publicado: (1952)

Chorionic gonadotropin and uterine dialogue in the primate
por: Cameo, Paula, et al.
Publicado: (2004)

IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Production of Mare Chorionic Girdle Organoids That Secrete Equine Chorionic Gonadotropin
por: Thompson, Riley E., et al.
Publicado: (2023)

Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day
por: Lee, Chun-I, et al.
Publicado: (2020)

Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
por: Santos, I. W., et al.
Publicado: (2010)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
por: Liu, ShuQin, et al.
Publicado: (2017)

Comparison of Oocyte Maturation Trigger Using Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin versus hCG Alone in Assisted Reproduction Technology Cycles
por: Dashti, Saeedeh, et al.
Publicado: (2019)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Luteinizing Hormone/Human Chorionic Gonadotropin Receptor N312S Single-Nucleotide Polymorphism and Its Impact on Clinical and Reproductive Outcomes in Assisted Reproductive Technology: A Prospective Cohort Study
por: Nagulapalli, Amulya, et al.
Publicado: (2023)

Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Early Embryogenesis: Review
por: d’Hauterive, Sophie Perrier, et al.
Publicado: (2022)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Human Chorionic Gonadotropin Priming Does Not Improve Pregnancy Outcomes of PCOS-IVM Cycles
por: Lin, Yihua, et al.
Publicado: (2020)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

Alpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by down-regulating PKA and CREB activation
por: Saryu Malhotra, Sudha, et al.
Publicado: (2015)

Lung nodule management in Covid-19: does postponed surveillance matter?
por: Ratnakumar, Ratnaprashanthika, et al.
Publicado: (2021)

Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
por: Kumar, Pratap, et al.
Publicado: (2014)

Clinical outcomes after assisted reproductive technology in twin pregnancies: chorionicity-based comparison
por: Sun, Luming, et al.
Publicado: (2016)

New discoveries on the biology and detection of human chorionic gonadotropin
por: Cole, Laurence A
Publicado: (2009)

Management of Nonpregnant Women with Elevated Human Chorionic Gonadotropin
por: Schmid, Bernd C., et al.
Publicado: (2013)

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
por: Lee, Regina, et al.
Publicado: (2015)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
por: De, Alpana, et al.
Publicado: (2018)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Does Postevacuation β-Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?
por: Mousavi, Azam Sadat, et al.
Publicado: (2014)

Determining an Optimal Cutoff of Serum β-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas
por: Zhang, Hui, et al.
Publicado: (2016)

A randomized controlled study to evaluate the cost-effectiveness in sperm extraction using carbon dioxide and carbon dioxide free system in relation to intrauterine insemination pregnancy
por: Bhakta, Rajesh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5mjpkqr01mavmtufkjtovv2h8b